Terms: = Lung cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874
108 results:
1. Demographic bias in misdiagnosis by computational pathology models.
Vaidya A; Chen RJ; Williamson DFK; Song AH; Jaume G; Yang Y; Hartvigsen T; Dyer EC; Lu MY; Lipkova J; Shaban M; Chen TY; Mahmood F
Nat Med; 2024 Apr; 30(4):1174-1190. PubMed ID: 38641744
[TBL] [Abstract] [Full Text] [Related]
2. If it's a target, it's a pan-cancer target: Tissue is not the issue.
Adashek JJ; Kato S; Sicklick JK; Lippman SM; Kurzrock R
Cancer Treat Rev; 2024 Apr; 125():102721. PubMed ID: 38522181
[TBL] [Abstract] [Full Text] [Related]
3. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract] [Full Text] [Related]
4. Decoding Serine Metabolism: Unveiling Novel Pathways for Evolving cancer Therapies.
Lau A; Blenis J; Burgos-Barragan G
Cancer Res; 2024 Apr; 84(8):1191-1194. PubMed ID: 38364233
[TBL] [Abstract] [Full Text] [Related]
5. Smokers and risk of hospital death by COVID calculated with SAVANA's natural language processing in the Castilla-La Mancha area.
Godoy R; Benavent Núñez M; Cruz J; López Yepes G; Parralejo Jiménez A; Callejas FJ; Izquierdo JL
Rev Clin Esp (Barc); 2024 Jan; 224(1):34-42. PubMed ID: 38142978
[TBL] [Abstract] [Full Text] [Related]
6. Wild-type idh1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway.
Zhang C; Yu JJ; Yang C; Yuan ZL; Zeng H; Wang JJ; Shang S; Lv XX; Liu XT; Liu J; Xue Q; Cui B; Tan FW; Hua F
Sci Transl Med; 2023 Dec; 15(726):eade4113. PubMed ID: 38091408
[TBL] [Abstract] [Full Text] [Related]
7. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
8. Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.
Biswas S; Mandal G; Anadon CM; Chaurio RA; Lopez-Bailon LU; Nagy MZ; Mine JA; Hänggi K; Sprenger KB; Innamarato P; Harro CM; Powers JJ; Johnson J; Fang B; Eysha M; Nan X; Li R; Perez BA; Curiel TJ; Yu X; Rodriguez PC; Conejo-Garcia JR
Immunity; 2023 Nov; 56(11):2570-2583.e6. PubMed ID: 37909039
[TBL] [Abstract] [Full Text] [Related]
9. Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery.
Yang S; Zhou C; Zhang L; Xiong Y; Zheng Y; Bian L; Liu X
Proteomics Clin Appl; 2024 Mar; 18(2):e2300010. PubMed ID: 37726528
[TBL] [Abstract] [Full Text] [Related]
10. Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial.
Freeman SD; Thomas A; Thomas I; Hills RK; Vyas P; Gilkes A; Metzner M; Jakobsen NA; Kennedy A; Moore R; Almuina NM; Burns S; King S; Andrew G; Gallagher KME; Sellar RS; Cahalin P; Weber D; Dennis M; Mehta P; Knapper S; Russell NH
Blood; 2023 Nov; 142(20):1697-1707. PubMed ID: 37595359
[TBL] [Abstract] [Full Text] [Related]
11. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
12. The Role of EGFR Amplification in Deep Venous Thrombosis Occurrence in idh Wild-Type Glioblastoma.
Kaye B; Ali A; Correa Bastianon Santiago RA; Ibrahim B; Isidor J; Awad H; Sabahi M; Obrzut M; Adada B; Ranjan S; Borghei-Razavi H
Curr Oncol; 2023 May; 30(5):4946-4956. PubMed ID: 37232831
[No Abstract] [Full Text] [Related]
13. Glioblastoma with novel EGFR mutations (T790M and exon 20 insertion) yet unresponsive to osimertinib: A case report.
Boongird A; Lekcharoensombat N; Jinawath A; Theparee T; Jittapiromsak N; Shuangshoti S; Thorner PS; Teerapakpinyo C
Genes Chromosomes Cancer; 2023 Jul; 62(7):423-429. PubMed ID: 36994936
[TBL] [Abstract] [Full Text] [Related]
14. Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
Duffau H
J Neurooncol; 2023 Mar; 162(1):237-244. PubMed ID: 36913047
[TBL] [Abstract] [Full Text] [Related]
15. DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.
Dillon LW; Gui G; Page KM; Ravindra N; Wong ZC; Andrew G; Mukherjee D; Zeger SL; El Chaer F; Spellman S; Howard A; Chen K; Auletta J; Devine SM; Jimenez Jimenez AM; De Lima MJG; Litzow MR; Kebriaei P; Saber W; Weisdorf DJ; Hourigan CS
JAMA; 2023 Mar; 329(9):745-755. PubMed ID: 36881031
[TBL] [Abstract] [Full Text] [Related]
16. STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell lung cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial.
Arcidiacono F; Anselmo P; Casale M; Zannori C; Ragusa M; Mancioli F; Marchetti G; Loreti F; Italiani M; Bracarda S; Maranzano E; Trippa F
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):886-896. PubMed ID: 36288758
[TBL] [Abstract] [Full Text] [Related]
17. FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma.
Gött H; Uhl E
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955806
[TBL] [Abstract] [Full Text] [Related]
18. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
[TBL] [Abstract] [Full Text] [Related]
19. Profiling the Effect of Targeting Wild Isocitrate Dehydrogenase 1 (idh1) on the Cellular Metabolome of Leukemic Cells.
Shait Mohammed MR; Alzahrani F; Hosawi S; Choudhry H; Khan MI
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743098
[TBL] [Abstract] [Full Text] [Related]
20. Incidental discovery of acute myeloid leukemia during liquid biopsy of a lung cancer patient.
Nkosi D; Miller CA; Jajosky AN; Oltvai ZN
Cold Spring Harb Mol Case Stud; 2022 Jun; 8(4):. PubMed ID: 35732498
[TBL] [Abstract] [Full Text] [Related]
[Next]
